FDA issues Regeneron a second complete response letter on its BLA for odronextamab and its use in relapsed/refractory follicular lymphoma after citing...
Allogene Therapeutics modifies its ALPHA3 clinical trial for large B-cell lymphoma following the death of a patient attributed to its investigational ...
FDA approves LENZ Therapeutics Vizz (aceclidine ophthalmic solution) 1.44% for treating presbyopia, a common age-related condition that causes blurry ...
Illumina agrees to pay $9.8 million to settle allegations that it violated the False Claims Act by selling genomic sequencing systems with known cyber...
Draeger recalls (Class 1) its SafeStar 90 Plus bidirectional breathing system filter after receiving reports of slow increase of CO2-curve when a gas ...
FDA approves Novo Nordisks Alhemo (concizumab-mtci) as a once-daily preventive treatment for bleeding episodes in patients 12 years and older with hem...
FDA says the Innovative Science and Technology Approaches for New Drugs pilot is transitioning into a permanent drug development tool qualification pr...
Politico reports that despite strong support from FDA commissioner Martin Makary and HHS secretary Robert F. Kennedy, Jr., President Trump insisted th...
